Related by context. Frequent words. (Click for all words.) 75 placebo controlled randomized 74 Phase III randomized 74 multicenter randomized double 73 multicenter randomized 73 prospective randomized controlled 73 randomized Phase III 73 randomized controlled 72 randomized placebo controlled 72 blind randomized placebo 71 double blind placebo 71 randomized controlled clinical 71 phase IIa 70 multicentre 70 randomized clinical 69 multicenter clinical 69 active comparator 69 prospective randomized 69 blind randomized 69 phase IIb 69 randomized double 69 blinded placebo controlled 69 placebo controlled 68 randomized 68 Phase 1b clinical 68 multicenter 67 Phase 1b trial 66 dose escalation trial 66 Phase 2a clinical 65 multicenter study 65 Phase 2b clinical 64 Phase 2b study 64 Randomized 64 randomized controlled trial 64 placebo controlled studies 64 Phase 2a trial 64 nab paclitaxel 64 placebo controlled trials 64 Phase Ia 63 SCH # 63 randomized Phase 63 Phase 1a 63 noninferiority 63 phase 2a 63 pharmacodynamics 63 substudy 63 label dose escalation 63 dose regimens 63 Phase Ib 62 randomized controlled trials 62 clinical trial 62 single ascending dose 62 TELCYTA 62 Phase IIa clinical 62 Phase IIb clinical 62 Phase IIa 62 axitinib 62 blind placebo controlled 62 temsirolimus 61 dose escalation 61 Phase 2b trial 61 Phase III clinical 61 neoadjuvant 61 dose cohorts 61 Phase IIa trial 61 Phase 1b 61 multiple ascending dose 61 SPIRIT III 61 safety tolerability pharmacokinetics 61 Phase III 61 randomized trials 60 BAY #-# 60 plus prednisone 60 prospective cohort 60 confirmatory Phase III 60 decitabine 60 randomized #:# 60 Phase IIb 60 dose escalation study 60 pivotal Phase III 60 intravenously administered 60 Phase IIb trial 60 randomized clinical trials 60 peginterferon alfa 2b 60 HGS ETR1 60 vicriviroc 60 metastatic renal cell carcinoma 59 tocilizumab 59 secondary efficacy endpoints 59 Pharmacokinetic 59 dabigatran etexilate 59 nitazoxanide 59 lacosamide 59 sunitinib 59 diabetic neuropathic pain 59 relapsed multiple myeloma 59 subgroup analyzes 59 Rosuvastatin 59 IMC A# 58 CoFactor 58 RTOG 58 Phase 2a